NSEShareholders meeting4h ago · 3 Oct 2026, 04:47 pm

Shareholders meeting

Lincoln Pharmaceuticals Limited · LINCOLN

✦ AI SummaryResults

Lincoln Pharmaceuticals Limited has informed the Exchange about the voting results of its 32nd Annual General Meeting held on September 30, 2026. The meeting approved the audited standalone and consolidated financial statements for the financial year ended March 31, 2026, and declared a dividend of Rs. 1.80 per equity share for the financial year 2025-2026. A director, Mr. Hashmukh I. Patel, was also re-appointed.

Analysis Scores

Earnings Impact2/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Lincoln Pharmaceuticals Limited has informed the Exchange a copy of Voting Results of Annual General Meeting held on September 30, 2026.

Attachments (1)

📄

LINCOLN_03102026163937_E_voting_and_Scrutinizer_report_merged.pdf

pdf

Download →
View document text
LINCOLN PHARMACEUTICALS L TO. HEAL THC:ARE FOR ALL Date: October 03, 2026 To To The Manager, The Manager, Listing Department, The Department of Corporate Service, National Stock Exchange of India Limited, BSE Limited, (BSE) (NSE) Phiroze Jeejeebhoy Tower, Exchange Plaza, C-1, Block-G, Bandra-Kurla Dalal Street, Complex, Bandra (E), Mumbai – 400 051. Mumbai – 400 001. Scrip Code – LINCOLN Scrip Code – 531633 Dear Sir / Madam, Sub.:Submission of Voting Result of 32nd Annual General Meeting along with the Scrutinizers’ Report as per Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. Pursuant to the provisions of Regulation 44 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that 32nd Annual General Meeting of the company was held on Wednesday, September 30, 2026 at 11:00 a.m. through Video Conferencing (VC)/Other Audio-Visual Means (OAVM) in accordance with the relevant circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India. We enclose herewith the details of the results of voting held through remote e-voting and e-voting at the AGM along with scrutinizer’s report on e-voting. Kindly take the same on your records. Thanking you, Yours faithfully, For Lincoln Pharmaceuticals Limited Trusha Shah Company Secretary & Compliance Officer Encl: a/a Regd. Office: "Lincoln House", Science City Road. Sola. Ahmedabad·380 060. Gujarat. India • Phone, +91-79-4107 8000 I Fax, +91-79-4107 8062 I CIN L24230GJ1995PLC024288 E-mail: info@lincolnpharma.com I Website: www.lincolnpharma.com Factory, 10, 12, 13, Trimul Estate, Near Khatraj Chokadi, P.O. Khatraj-382721. lntertek • •• Ta., Kaloi, Dist Gandhinagar, IGuj.1 I Phone, +91-79-49135000 I E-mail, khatraj@lincolnpharma.com LINCOLN PHARMACEUTICALS L TO. HEAL THC:ARE FOR ALL Voting Results at the 32nd Annual General Meeting of the Company. Name of the Company Lincoln Pharmaceuticals Limited Date of the Annual General Meeting Wednesday, September 30, 2026 Total No. of Shareholders as on Record Date 29,882 No. of shareholders present in the meeting either in person or through proxy A. Promoter / Promoter Group NA B. Public NA No. of Shareholders attended the meeting through Video Conferencing A. Promoter / Promoter Group 18 B. Public 62 Details of remote e-voting and e-voting at the AGM as per regulation 44 of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015. ORDINARY BUSINESSES: Resolution No. 1 To receive, consider and adopt the audited Standalone and Consolidated financial statements of the Company for the financial year ended March 31, 2026, the reports Resolution Required: Ordinary of Board of Directors and Auditors thereon. Whether Promoter / Promoter group are interested in the agenda / No resolution % of votes % of votes % of votes polled on in favour against on the No. of Mode of No. of Share No. of Votes No. of votes on votes votes Category Outstanding votes Voting Held polled in favour polled polled Shares against =[(4)/(2)] = [(5)/(2)] = [(2)/(1)] * 100 * 100 * 100 Promoter Remote E- 93,05,356 93.33 93,05,356 0 100.00 0.00 and Voting 99,69,930 Promoter Poll* 0 0.00 0 0 0.00 0.00 Group Total 99,69,930 93,05,356 93.33 93,05,356 0 100.00 0.00 Remote E- 5,00,540 54.27 5,00,148 392 99.92 0.08 Public – Voting 9,22,286 Institutions Poll* 0 0.00 0 0 0.00 0.00 Total 9,22,286 5,00,540 54.27 5,00,148 392 99.92 0.08 Remote E- Public – 13,77,821 15.08 13,77,151 670 99.95 0.05 Voting 91,37,512 Non- Poll* 8,350 0.09 8,350 0 100.00 0.00 Institutions Total 91,37,512 13,86,171 15.17 13,85,501 670 99.95 0.05 Total 2,00,29,728 1,11,92,067 55.88 1,11,91,005 1,062 99.99 0.01 The above resolution was declared to have been passed with requisite majority as an Ordinary Resolution. Regd. Office: "Lincoln House", Science City Road. Sola. Ahmedabad·380 060. Gujarat. India • Phone, +91-79-4107 8000 I Fax, +91-79-4107 8062 I CIN L24230GJ1995PLC024288 E-mail: info@lincolnpharma.com I Website: www.lincolnpharma.com Factory, 10, 12, 13, Trimul Estate, Near Khatraj Chokadi, P.O. Khatraj-382721. lntertek • •• Ta., Kaloi, Dist Gandhinagar, IGuj.1 I Phone, +91-79-49135000 I E-mail, khatraj@lincolnpharma.com LINCOLN PHARMACEUTICALS L TO. HEAL THC:ARE FOR ALL Resolution No. 2 To declare dividend of Rs. 1.80/- (i.e.18%) per equity share of Rs. 10/- each for the financial year 2025-2026. Resolution Required: Ordinary Whether Promoter / Promoter group are interested in the agenda / No resolution % of votes % of polled on votes in % of votes the No. of favour on against on Mode of No. of Share No. of Votes No. of votes Category Outstanding votes votes votes polled Voting Held polled in favour Shares against polled = [(5)/(2)] = [(2)/(1)] =[(4)/(2)] * 100 * 100 * 100 Promoter Remote E- 93,05,356 93.33 93,05,356 0 100.00 0.00 and Voting 99,69,930 Promoter Poll* 0 0.00 0 0 0.00 0.00 Group Total 99,69,930 93,05,356 93.33 93,05,356 0 100.00 0.00 Remote E- Public – 5,10,418 55.34 5,10,418 0 100.00 0.00 Voting 9,22,286 Institution Poll* 0 0.00 0 0 0.00 0.00 Total 9,22,286 5,10,418 55.34 5,10,418 0 100.00 0.00 Public – Remote E- 13,77,821 15.08 13,77,776 45 100.00 0.00 Non- Voting 91,37,512 Institution Poll* 8,350 0.09 8,350 0 100.00 0.00 s Total 91,37,512 13,86,171 15.18 13,86,126 45 100.00 0.00 Total 2,00,29,728 1,12,01,945 55.93 1,12,01,900 45 100.00 0.00 The above resolution was declared to have been passed with requisite majority as an Ordinary Resolution. Resolution No. 3 To appoint a director in place of Mr. Hashmukh I. Patel [DIN: 00104834], who retires by rotation and being eligible offers himself for re-appointment as a Director. Resolution Required: Ordinary Whether Promoter / Promoter group are interested in the agenda / Yes resolution % of % of votes votes in % of votes polled on favour against on the No. of Mode of No. of Share No. of Votes No. of votes on votes votes Category Outstandin votes Voting Held polled in favour polled polled g Shares against =[(4)/( = [(5)/(2)] = [(2)/(1)] 2)] * 100 * 100 * 100 Promoter Remote E- 93,05,356 93.33 93,05,356 0 100.00 0.00 and Voting 99,69,930 Promoter Poll* 0 0.00 0 0 0.00 0.00 Group Total 99,69,930 93,05,356 93.33 93,05,356 0 100.00 0.00 Remote E- Public – 5,10,418 55.34 3,482 5,06,936 0.68 99.32 Voting 9,22,286 Institution Poll* 0 0.00 0 0 0.00 0.00 Total 9,22,286 5,10,418 55.34 3,482 5,06,936 0.68 99.32 Public – Remote E- 13,77,821 15.26 13,77,084 737 99.95 0.05 Non- Voting 91,37,512 Institution Poll* 8,350 0.09 8,350 0 100.00 0.00 s Total 91,37,512 13,86,171 15.35 13,85,434 737 99.95 0.05 Total 2,00,29,728 1,12,01,945 55.93 1,06,94,272 5,07,673 95.47 4.53 The above resolution was declared to have been passed with requisite majority as an Ordinary Resolution. Regd. Office: "Lincoln House", Science City Road. Sola. Ahmedabad·380 060. Gujarat. India • Phone, +91-79-4107 8000 I Fax, +91-79-4107 8062 I CIN L24230GJ1995PLC024288 E-mail: info@lincolnpharma.com I Website: www.lincolnpharma.com Factory, 10, 12, 13, Trimul Estate, Near Khatraj Chokadi, P.O. Khatraj-382721. lntertek • •• Ta., Kaloi, Dist Gandhinagar, IGuj.1 I Phone, +91-79-49135000 I E-mail, khatraj@lincolnpharma.com LINCOLN PHARMACEUTICALS L TO. HEAL THC:ARE FOR ALL Resolution No. 4 To appoint a director in place of Mr. Munjal Mahendrabhai Patel [DIN: 02319308], who retires by rotation and being eligible offers himself for re-appointment as a Resolution Required: Ordinary director. Whether Promoter / Promoter group are interested in the agenda / resolution % of votes % of polled on votes in % of votes the favour Mode No. of against on No. of Share No. of Votes Outstandi No. of votes on votes Category of votes votes polled Held polled ng in favour polled Voting against = [(5)/(2)] Shares =[(4)/( * 100 [(2)/(1)] * 100 * 100 Remote Promoter E- 93,05,356 93.33 93,05,356 0 100.00 0.00 and 99,69,930 Voting Promoter Poll* 0 0.00 0 0 0.00 0.00 Group [Showing first 8,000 characters — download PDF for full document]